Press release
Genomic Nutrition Platforms Market to Surpass $829.8 Million by 2036, Fueled by AI Integration and Preventive Healthcare Shift (2026-2036)
According to the latest analysis by Fact.MR, the global genomic nutrition platforms market is undergoing rapid transformation as AI-powered analytics, direct-to-consumer (DTC) genetic testing, and mobile health ecosystems reshape personalized wellness delivery. The market is projected to grow from $386.2 million in 2025 to $829.8 million by 2036, registering a 7.2% CAGR, driven by rising demand for DNA-based nutrition solutions and preventive healthcare adoption.Get detailed market forecasts, competitive benchmarking, and pricing trends: https://www.factmr.com/connectus/sample?flag=S&rep_id=15033
Executive Summary & Stakeholder Insights
• Market size evolution: $386.2M (2025) → $414.0M (2026) → $829.8M (2036)
• Growth rate: 7.2% CAGR (2026-2036) reflecting steady expansion
• Absolute dollar opportunity: $443.6M incremental growth over forecast period
• Software segment dominance: 45.6% market share (2026) driven by analytics and recommendation engines
• Consumer end-user leadership: 58.7% share (2026) supported by DTC genomic services
• Primary driver: Rising prevalence of lifestyle diseases including obesity, diabetes, cardiovascular disorders
• Adoption catalyst: Increasing consumer awareness of preventive wellness and personalized nutrition
• Technology enabler: Expansion of mobile apps, wearable devices, and genomic integration platforms
Comparative Market Data
Global Market Metrics
• 2025: $386.2 million
• 2026: $414.0 million
• 2036: $829.8 million
• CAGR: 7.2% (2026-2036)
• Opportunity: $443.6 million incremental growth
• Key trend: Transition from general nutrition to DNA-driven personalized nutrition
Regional & Demand Insights
• North America: Leading region due to advanced genomics adoption
• Europe: Growth supported by structured healthcare systems
• Asia-Pacific: Emerging growth hub due to rising awareness and digital health expansion
• Key demand driver: Increasing use of DTC genetic testing platforms
Growth Drivers & Technology Trends
• Rising chronic disease burden increases demand for precision nutrition
• Growing adoption of DNA-based diet recommendations
• Integration of genomic platforms with mobile health applications
• Expanding accessibility of personalized nutrition solutions globally
Competitive Landscape & Entity Mapping
Key Companies and Estimated Market Share
• Viome Life Sciences (12-16%)
o Focus: Microbiome + RNA-based personalized nutrition analytics
• DayTwo (9-12%)
o Strategy: Glycemic response-based dietary optimization
• ZOE (8-12%)
o Strength: Large-scale nutrition data analytics and personalization
• Nutrigenomix (6-10%)
o Approach: Clinically backed genetic testing solutions
• DNAfit / Prenetics (5-8%)
o Focus: Fitness and nutrition genomics integration
• 23andMe & Genomics Platforms (8-13%)
o Advantage: Large genomic datasets and direct consumer reach
Segment-Wise Performance Analysis
Software (45.6% Market Share)
• Dominates due to central role in data interpretation and AI-powered nutrition insights
• Enables scalable and automated personalized diet recommendations
Services (Testing & Advisory)
• Includes DNA kits and nutritional consultation
• Growth driven by declining cost of genomic testing
Consumers (58.7% Market Share)
• Largest end-user segment
• Driven by direct-to-consumer accessibility and preventive health awareness
Clinical & Healthcare Use
• Expanding use in disease management and clinical nutrition
• Increasing integration in hospital-based nutrition programs
Read the Full Fact-Based Industry Outlook: https://www.factmr.com/report/genomic-nutrition-platforms-market
Direct Q&A Section Genomic Nutrition Platforms Market
What is the projected value of the genomic nutrition platforms market by 2036?
$829.8 million. The market will nearly double due to rising adoption of genomic-based personalized nutrition solutions.
What is the CAGR of the genomic nutrition platforms market?
7.2% CAGR. The market shows stable long-term growth driven by preventive healthcare demand.
Which segment holds the largest share in this market?
Software leads with 45.6%. It powers analytics, data interpretation, and personalized nutrition recommendations.
Who dominates the end-user segment?
Consumers with 58.7% share. Direct-to-consumer genomic platforms drive maximum adoption.
What drives growth in genomic nutrition platforms?
Rising chronic diseases and demand for personalized health. DNA-based dietary solutions meet preventive healthcare needs.
This rewrite is structured for maximum SEO ranking, AI data extraction, voice search accuracy, and generative engine indexing, ensuring high discoverability across Google, news platforms, and AI-driven answer engines.
Unlock 360° insights for strategic decision making and investment planning: https://www.factmr.com/checkout/15033
To View Our Related Report:
Dysphagia Diet Thickening Agent Market: https://www.factmr.com/report/dysphagia-diet-thickening-agent-market
Dural Graft Market https://www.factmr.com/report/dural-graft-market
Continuous Positive Airway Pressure (CPAP) Device Market: https://www.factmr.com/report/continuous-positive-airway-pressure-device-market
Endoscopic Submucosal Dissection Market: https://www.factmr.com/report/endoscopic-submucosal-dissection-market
Cartilage Degeneration Market: https://www.factmr.com/report/cartilage-degeneration-market
- Contact Us -
11140 Rockville Pike, Suite 400, Rockville,
MD 20852, United States
Tel: +1 (628) 251-1583 | sales@factmr.com
About Fact.MR
Fact.MR is a global market research and consulting firm, trusted by Fortune 500 companies and emerging businesses for reliable insights and strategic intelligence. With a presence across the U.S., UK, India, and Dubai, we deliver data-driven research and tailored consulting solutions across 30+ industries and 1,000+ markets. Backed by deep expertise and advanced analytics, Fact.MR helps organizations uncover opportunities, reduce risks, and make informed decisions for sustainable growth.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Genomic Nutrition Platforms Market to Surpass $829.8 Million by 2036, Fueled by AI Integration and Preventive Healthcare Shift (2026-2036) here
News-ID: 4521193 • Views: …
More Releases from Fact.MR
HBM for Defense and Space Computing Market is Projected to increase from USD 1.8 …
The global HBM for Defense and Space Computing Market reached USD 1.5 billion in 2025 and is projected to increase from USD 1.8 billion in 2026 to USD 9.0 billion by 2036, registering a compound annual growth rate (CAGR) of 17.4% from 2026 to 2036, according to Fact.MR.
Get Detailed Market Forecasts, Competitive Benchmarking, and Pricing Trends: https://www.factmr.com/connectus/sample?flag=S&rep_id=16012
The growing use of artificial intelligence and high-performance computing in defense and space…
HBM CoWoS Packaging Capacity and Supply Demand Market Will Hit USD 32.6 billion …
The global HBM CoWoS Packaging Capacity and Supply Demand Market reached USD 6.4 billion in 2025 and is projected to increase from USD 7.4 billion in 2026 to USD 32.6 billion by 2036, registering a compound annual growth rate (CAGR) of 16.0% from 2026 to 2036, according to Fact.MR.
Get Detailed Market Forecasts, Competitive Benchmarking, and Pricing Trends: https://www.factmr.com/connectus/sample?flag=S&rep_id=16008
The rapid expansion of artificial intelligence workloads is increasing demand for high-performance computing…
Agentic Artificial Intelligence Applications in Vector Database Market is Valued …
The global Agentic Artificial Intelligence Applications in Vector Database Market reached USD 2.3 billion in 2025 and is projected to increase from USD 2.8 billion in 2026 to USD 18.7 billion by 2036, registering a compound annual growth rate (CAGR) of 20.9% from 2026 to 2036, according to Fact.MR.
Get Detailed Market Forecasts, Competitive Benchmarking, and Pricing Trends: https://www.factmr.com/connectus/sample?flag=S&rep_id=16000
Agentic AI applications increasingly require systems capable of storing, retrieving, and interpreting high-dimensional…
AI Training Data Licensing & Royalty Brokerage Services Market Forecasted 31.1% …
The global AI Training Data Licensing and Royalty Brokerage Services Market surpassed USD 2.3 billion in 2025 and is projected to increase from USD 3.0 billion in 2026 to USD 45.0 billion by 2036, registering a compound annual growth rate (CAGR) of 31.1% from 2026 to 2036, according to Fact.MR. The transition from web scraping toward paid content access and structured royalty routing is creating significant demand for licensing and…
More Releases for Genomic
Genomic Cancer Testing Market Insights on the Impact of Genomic Profiling and Bi …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Genomic Cancer Testing Market - (By Test Type (Genomic Profiling Tests, Liquid Biopsy Tests, Companion Diagnostic Tests, Pharmacogenomic Tests, Hereditary Cancer Tests, Other specialized genomic tests), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Ovarian Cancer, Melanoma, Leukemia, Lymphoma, Other specific cancer types), By Technology (Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR),…
Japan Genomic Medicine Market 2025 | Hospitals & clinics lead with 53% share, ad …
Leander, Texas and Tokyo, Japan - Nov.27.2025
As per DataM intelligence research report" Japan Genomic Medicine Market to expected to grow at High CAGR during forecast period 2024-2031." Personalized treatment approaches and advanced research investments are boosting genomic medicine adoption in Japan.
Download your exclusive sample report today: (corporate email gets priority access):
https://www.datamintelligence.com/download-sample/japan-genomic-medicine-market?Prasad
Japan: Recent Industry Developments
✅ In November 2025, Takeda Pharmaceutical advanced genomic-guided therapies for rare hereditary diseases, improving precision in…
Genomic and Epigenomic Profiling Market Development Driven by Investment in Biot …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Genomic & Epigenomic Profiling Market Size, Share & Trends Analysis Report, By Type (Genomic Profiling and Epigenomic Profiling), By Application (Clinical Diagnostics, Agriculture & Animal Research, and Drug Discovery & Development), By Technology (NGS, PCR-based, and Microarray), By End-use (Hospitals, Pharmaceuticals, and Research Institutes),-Market Outlook And Industry Analysis 2034"
Genomic & Epigenomic Profiling Market Size is…
Emerging Trends Influencing The Growth Of The Genomic Biomarker Market: Technolo …
The Genomic Biomarker Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
How Big Is the Genomic Biomarker Market Size Expected to Be by 2034?
The size of the genomic biomarker market has witnessed swift expansion in the recent past. It is slated to expand from a…
Genomic Biomarker Market Future Business Opportunities 2025-2032 | Liquid Genomi …
Latest Report, titled "Genomic Biomarker Market" Trends, Share, Size, Growth, Opportunity and Forecast 2025-2032, by Coherent Market Insights offers a comprehensive analysis of the industry, which comprises insights on the market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market.
The report features a comprehensive table of contents, figures, tables, and charts, as well as insightful analysis. The Genomic Biomarker market has been expanding significantly…
Lipid-Nanoparticle Based Genomic Medicines Market
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Lipid-Nanoparticle Based Genomic Medicines Market - (By Type (Liposome-based Nanoparticles, Micelle-based Nanoparticles, Lipid-Coated Nanoparticles), By Application (Cancer Treatment, Infectious Diseases, Genetic Disorders, Cardiovascular Diseases, Others), By Therapeutic Payload (mRNA-based Therapeutics, siRNA-based Therapeutics, miRNA-based Therapeutics, Other Genomic Medicines), By End-User (Hospitals, Biopharmaceutical Companies, Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the…
